Ghrelin (Peptide) : The Gastric Hunger Signal, Growth Hormone Liberator, Metabolic State Sensor

Ghrelin is the only known circulating appetite-stimulating hormone, a 28-amino acid peptide produced in the stomach that rises before meals and falls after eating, serving as a biological clock for meal initiation while orchestrating growth hormone release, glucose homeostasis, and cardiovascular protection.

---

1. Overview:

Ghrelin is a gastric peptide hormone discovered in 1999 as the endogenous ligand for the growth hormone secretagogue receptor (GHSR). It is the only circulating peripheral hormone known to promote a positive energy balance by stimulating food intake, increasing fat storage, and decreasing energy expenditure . Ghrelin exists in two primary forms: acylated ghrelin (the bioactive form) and desacyl ghrelin (the more abundant but typically inactive form). Beyond its role as the "hunger hormone," ghrelin exerts pleiotropic effects throughout the body, including growth hormone secretion, gastric motility, glucose regulation, cardiovascular protection, anti-inflammatory actions, bone formation, and neuroprotection .

---

2. Origin & Common Forms:

Ghrelin is an endogenous peptide hormone primarily produced by P/D1 cells (formerly called X/A-like cells) in the fundus of the stomach, representing approximately 20% of gastric mucosal cells in humans . Smaller amounts are also produced in the duodenum, jejunum, ileum, colon, pancreas, kidney, pituitary, hypothalamus, and other tissues. The ghrelin gene (GHRL) is located on the short arm of chromosome 3 (3p25-26) .

---

3. Common Supplemental Forms: Standard & Enhanced

Ghrelin itself is not available as a consumer supplement due to its peptide structure and short half-life. However, various pharmaceutical agents have been developed to target the ghrelin system:

· Synthetic Ghrelin (Acylated Ghrelin): Used exclusively in clinical research settings as an intravenous infusion. An ongoing phase 2 trial (MR GENTLE) is investigating intravenous acylated ghrelin (600 mcg twice daily for 5 days) in stroke patients .

· Ghrelin Receptor Agonists (GHSR-1a agonists): Synthetic small molecules that activate the ghrelin receptor. Examples include ibutamoren (MK-0677) and anamorelin. Anamorelin is approved in some countries for treating cancer cachexia (wasting syndrome). These have longer half-lives than native ghrelin .

· Ghrelin Receptor Antagonists: Compounds like JMV2959 that block the ghrelin receptor, under investigation for obesity and metabolic disorders .

---

4. Natural Origin:

· Endogenous Source: Produced by enteroendocrine cells in the gastric mucosa, with the highest concentration in the stomach.

· Precursors: The ghrelin gene (GHRL) encodes preproghrelin (117 amino acids), which is processed to proghrelin and then to the mature 28-amino acid ghrelin peptide. The unique post-translational modification acylation (addition of an octanoyl group to serine 3) is catalyzed by the enzyme ghrelin O-acyl transferase (GOAT) .

· Dietary Influence: Ingestion of medium-chain fatty acids or medium-chain triglycerides increases ghrelin acylation. No direct dietary precursors for ghrelin itself exist, as it is an endogenous hormone .

---

5. Synthetic / Man-made:

· Process: Synthetic acylated ghrelin for research purposes is produced via solid-phase peptide synthesis, incorporating the octanoyl group at the third serine position. For the MR GENTLE stroke trial, acylated ghrelin was independently manufactured at the Leiden University Medical Centre. Non-peptide small-molecule ghrelin receptor agonists and antagonists are produced via medicinal chemistry synthesis .

---

6. Commercial Production:

· Precursors: Amino acids and chemical reagents for peptide synthesis.

· Process: Solid-phase peptide synthesis followed by purification via high-performance liquid chromatography (HPLC). For pharmaceutical agonists like anamorelin, large-scale chemical synthesis is used.

· Purity & Efficacy: Research-grade and pharmaceutical-grade preparations are highly purified. The short half-life of native ghrelin (approximately 30 minutes) limits its practical use, driving development of more stable synthetic analogs .

---

7. Key Considerations:

The Acylation Requirement. Ghrelin is the only known peptide hormone modified by a fatty acid. The octanoyl group on serine 3 is essential for binding to and activating the ghrelin receptor (GHSR-1a). Desacyl ghrelin (without this modification) makes up more than 90% of circulating ghrelin and is largely inactive at the canonical receptor, though it may have some distinct effects. This unique acylation mechanism, catalyzed by GOAT, represents a potential drug target for modulating ghrelin activity .

---

8. Structural Similarity:

A 28-amino acid peptide with a unique n-octanoylation modification on the serine residue in position 3. The structure includes an amidated C-terminus. The octanoyl chain is required to form a well-defined hydrophobic core that facilitates receptor binding. Cryo-electron microscopy studies have revealed that the peptide moiety occupies one cavity of the GHSR-1a receptor while the octanoyl chain occupies a second hydrophobic cavity .

---

9. Biofriendliness:

· Utilization: Following secretion from gastric cells, ghrelin enters the bloodstream and crosses the blood-brain barrier via a transport system to act on the hypothalamus. It also acts locally on the vagus nerve .

· Half-Life & Metabolism: The half-life of acylated ghrelin is very short, approximately 30 minutes. It is rapidly degraded in the circulation, which limits its therapeutic applicability. Ghrelin analogs with enhanced pharmacokinetics are under development to address this limitation .

· Toxicity: Excellent safety profile based on studies in over 1,850 participants. Mild adverse events occur in approximately 20% of recipients, with transient flushing being the most common (10%). Serious adverse events are rare. Ghrelin has been safely administered to patients with cardiovascular disease, neurodegenerative disease, and post-cardiac arrest .

---

10. Known Benefits (Clinically Supported):

· Appetite Stimulation & Weight Gain: The primary function is to increase food intake and promote fat storage. Ghrelin levels rise before meals and fall after eating. Administration of ghrelin increases appetite and food intake in both healthy individuals and patients with cachexia .

· Growth Hormone Secretion: Ghrelin is a potent stimulator of growth hormone release from the pituitary gland, acting through GHSR-1a .

· Gastric Motility: Stimulates gastric emptying and gastrointestinal motility .

· Cardiovascular Protection: Ghrelin has demonstrated cardioprotective effects and is being investigated for potential benefits in heart failure and stroke recovery .

· Neuroprotection: Exhibits neuroprotective effects in models of neurodegenerative diseases including Parkinson's and Alzheimer's, and may promote neurogenesis and synaptogenesis .

---

11. Purported Mechanisms:

· GHSR-1a Activation: Binds to the growth hormone secretagogue receptor (GHSR-1a), a G-protein coupled receptor (GPCR). This receptor couples primarily to Gαq/11 proteins, promoting calcium mobilization from intracellular stores through activation of phospholipase C. It also signals through other G protein isoforms including Gαi/o and Gα13 as well as β-arrestin scaffold proteins .

· Hypothalamic Action: Ghrelin acts on the lateral hypothalamus (the hunger center) to stimulate appetite. It activates AgRP (agouti-related protein) neurons and inhibits POMC (pro-opiomelanocortin) neurons in the arcuate nucleus .

· Constitutive Activity: The ghrelin receptor shows one of the highest constitutive signaling activities in the GPCR family, evoking signals at around 50% of the maximal ghrelin response even without ligand binding. This high basal activity has implications for drug development .

· Receptor Dimerization: GHSR-1a can form homodimers and heterodimers with a variety of GPCRs, including dopamine D1 and D2 receptors, serotonin 5-HT2c receptor, orexin OX1 receptor, and cannabinoid CB2 receptor, adding complexity to its signaling .

---

12. Other Possible Benefits Under Research:

· Stroke Recovery (Ongoing Phase 2 Trial - MR GENTLE): Investigating intravenous acylated ghrelin started within 6 hours of symptom onset in patients with ischemic stroke treated with endovascular thrombectomy .

· Cachexia Treatment: Ghrelin receptor agonists (e.g., anamorelin) are approved for cancer cachexia. Quinolone-based compounds are being explored as novel GHSR-1a agonists for cachexia treatment .

· Glucose Metabolism: Ghrelin decreases insulin release and increases plasma glucose. The endogenous antagonist LEAP2 (liver-expressed antimicrobial peptide 2) counteracts ghrelin and is under investigation for improving glucose tolerance .

· Psychiatric & Addiction Disorders: Ghrelin has been implicated in depression, anxiety, substance abuse disorders, and reward-seeking behavior .

· Bone Formation: Ghrelin plays a role in bone metabolism and formation .

---

13. Side Effects (Exogenous Administration):

· Minor & Transient: Transient flushing (most common, ~10%), gastric rumbling (~2.3%), temporary somnolence, fatigue, vertigo, or mood changes (~2.8%) .

· Serious But Rare: Serious adverse events such as pneumonia, enteritis, and lung cancer were rare in studies and most likely not related to ghrelin administration. Discontinuation due to adverse events was extremely low (3 of 939 participants) .

· Endogenous Ghrelin: No side effects from natural endogenous ghrelin production.

---

14. Dosing & How to Take:

· Clinical Research (Intravenous): In the MR GENTLE stroke trial, the dose is 600 mcg acylated ghrelin administered intravenously twice daily for 5 days, started within 6 hours of symptom onset .

· Approved Pharmaceuticals: Anamorelin (cachexia) is taken orally as a tablet.

· Not Available as a Consumer Supplement: Ghrelin itself is not available over the counter due to its peptide nature, short half-life, and requirement for parenteral administration.

---

15. Tips to Optimize Endogenous Ghrelin Function:

· Meal Timing and Frequency: Ghrelin levels naturally rise before scheduled meals. Consistent meal timing helps regulate the natural ghrelin rhythm.

· Sleep Duration: Sleep deprivation increases ghrelin levels, which can contribute to increased appetite and weight gain. Aim for at least 7-8 hours of sleep nightly .

· Stress Management: Chronic stress may increase ghrelin levels, potentially promoting stress-related eating .

· Diet Quality: Eating foods high in protein or healthy carbohydrates lowers ghrelin levels more effectively than high-fat foods. Avoid yo-yo dieting, as caloric restriction increases ghrelin levels and can promote weight regain .

· Hydration: Ghrelin levels may decrease when hydrated and increase when dehydrated .

---

16. Not to Exceed / Warning / Interactions:

· Clinical Research Context: Ghrelin administration in research settings is strictly controlled. The MR GENTLE trial specifies a dose of 600 mcg twice daily for 5 days .

· Pharmaceutical Ghrelin Agonists: Anamorelin and similar drugs have specific prescribing information, contraindications, and drug interactions that must be followed.

· Not for Self-Administration: There is no approved consumer form of ghrelin supplementation. Self-administration of ghrelin or unregulated "ghrelin mimetics" is strongly discouraged.

· Medical Conditions: People with known hypersensitivity to ghrelin or its components should avoid pharmaceutical preparations. Bariatric surgery (gastric bypass, sleeve gastrectomy) results in sustained lower ghrelin levels, contributing to long-term weight control .

---

17. LD50 & Safety:

· Acute Toxicity (LD50): Not applicable for an endogenous hormone.

· Human Safety: Excellent safety profile in clinical studies involving over 1,850 participants. Ghrelin has been safely administered to diverse populations including healthy individuals and patients with obesity, cancer, cardiovascular disease, neurodegenerative disease, and post-cardiac arrest .

---

18. Consumer Guidance:

· Label Literacy: Consumers will not find "ghrelin" as an ingredient in dietary supplements. Be wary of products claiming to "boost ghrelin" or act as "ghrelin supplements," as these are not regulated pharmaceutical products.

· Focus on Endogenous Regulation: The most effective way to work with your body's ghrelin system is through lifestyle factors: regular meal timing, adequate sleep, stress management, and a balanced diet rich in protein and healthy carbohydrates.

· LEAP2 Understanding: The endogenous ghrelin receptor antagonist LEAP2 is an area of active research. Its role in human metabolism is being investigated, but it is not a consumer supplement .

· Manage Expectations: Ghrelin is a fascinating hormone that orchestrates hunger, growth hormone release, and metabolic state. For most healthy individuals, the focus should be on supporting healthy ghrelin rhythms through lifestyle, not on attempting to directly manipulate ghrelin levels. Therapeutic ghrelin modulation is currently the domain of clinical research and prescription pharmaceuticals for specific conditions like cachexia.